StockData
Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc. (PBSV) stock

PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 9/30
$0.48+0.08 (+20.00%)

Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –

Pharma-Bio Serv net income

Net income is the profit left for shareholders after every expense, interest and tax.

Pharma-Bio Serv's net income for the twelve months ending Jul 31, 2026 was $251.53K. For fiscal 2025 it was -$100.46K. The highest annual figure on record is $4.91M in fiscal 2013.

Annual net income

PeriodPeriod endValueChange
FY2025Oct 31, 2025-$100.46K–
FY2024Oct 31, 2024-$777.62K-159.4%
FY2023Oct 31, 2023$1.31M+30.1%
FY2022Oct 31, 2022$1.01M–
FY2021Oct 31, 2021-$2.09M-201.9%
FY2020Oct 31, 2020$2.05M-1.7%
FY2019Oct 31, 2019$2.09M+63.1%
FY2018Oct 31, 2018$1.28M–
FY2017Oct 31, 2017-$1.41M–
FY2016Oct 31, 2016-$256.58K-115.8%
FY2015Oct 31, 2015$1.62M-32.7%
FY2014Oct 31, 2014$2.41M-50.8%
FY2013Oct 31, 2013$4.91M+4.7%
FY2012Oct 31, 2012$4.69M+48.4%
FY2011Oct 31, 2011$3.16M+749.4%
FY2010Oct 31, 2010$371.91K–

Quarterly net income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jul 31, 2026-$14.22K–
Q2 FY2026CQ1 2026Apr 30, 2026$232.99K+144.3%
Q1 FY2026CQ4 2025Jan 31, 2026$32.86K+285.0%
Q4 FY2025CQ3 2025Oct 31, 2025-$102-100.6%
Q3 FY2025CQ2 2025Jul 31, 2025-$204.25K–
Q2 FY2025CQ1 2025Apr 30, 2025$95.35K–
Q1 FY2025CQ4 2024Jan 31, 2025$8.54K–
Q4 FY2024CQ3 2024Oct 31, 2024$16.11K–
Q3 FY2024CQ2 2024Jul 31, 2024-$309.19K-158.8%
Q2 FY2024CQ1 2024Apr 30, 2024-$213.82K-152.8%
Q1 FY2024CQ4 2023Jan 31, 2024-$270.72K-163.5%
Q4 FY2023CQ3 2023Oct 31, 2023-$47.15K-105.7%
Q3 FY2023CQ2 2023Jul 31, 2023$526.24K–
Q2 FY2023CQ1 2023Apr 30, 2023$404.65K–
Q1 FY2023CQ4 2022Jan 31, 2023$426.43K-81.3%
Q1 FY2022CQ4 2021Jul 31, 2022$833.31K+246.8%
Q2 FY2022CQ1 2022Apr 30, 2022-$288.03K-207.5%
Q4 FY2021CQ3 2021Oct 31, 2021-$4.87M-3475.7%
Q3 FY2021CQ2 2021Jul 31, 2021$2.28M+228.7%
Q2 FY2021CQ1 2021Apr 30, 2021$240.27K-65.1%
Q1 FY2021CQ4 2020Jan 31, 2021$268.03K-49.1%
Q4 FY2020CQ3 2020Oct 31, 2020$144.35K-69.8%
Q3 FY2020CQ2 2020Jul 31, 2020$692.11K+60.5%
Q2 FY2020CQ1 2020Apr 30, 2020$687.56K-2.8%
Q1 FY2020CQ4 2019Jan 31, 2020$526.90K+11.9%
Q4 FY2019CQ3 2019Oct 31, 2019$477.60K-85.7%
Q3 FY2019CQ2 2019Jul 31, 2019$431.16K-41.0%
Q2 FY2019CQ1 2019Apr 30, 2019$707.48K–
Q1 FY2019CQ4 2018Jan 31, 2019$471.02K–
Q4 FY2018CQ3 2018Oct 31, 2018$3.34M–
Q3 FY2018CQ2 2018Jul 31, 2018$730.63K–
Q2 FY2018CQ1 2018Apr 30, 2018-$128.35K–
Q1 FY2018CQ4 2017Jan 31, 2018-$2.66M–
Q4 FY2017CQ3 2017Oct 31, 2017-$547.03K–
Q3 FY2017CQ2 2017Jul 31, 2017-$162.98K–
Q2 FY2017CQ1 2017Apr 30, 2017-$322.76K–
Q1 FY2017CQ4 2016Jan 31, 2017-$382.14K–
Q4 FY2016CQ3 2016Oct 31, 2016-$513.32K–
Q3 FY2016CQ2 2016Jul 31, 2016-$130.47K–

More Pharma-Bio Serv figures

See a number that looks wrong?